Evidence map›Paper›PMID 29248459›Full record

ArticleThe American journal of pathology2018

Discrete Pools of Oligomeric Amyloid-β Track with Spatial Learning Deficits in a Mouse Model of Alzheimer Amyloidosis.

Angie C A Chiang, Stephanie W Fowler, Rohit Reddy, Olga Pletnikova, Juan C Troncoso, Mathew A Sherman, Sylvain E Lesne, Joanna L Jankowsky

Erratum issuedAbstract read
In one paragraph

Article in The American journal of pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Aβ and Tau Prions Causing Alzheimer's Disease.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  3. Aβ and tau prions feature in the neuropathogenesis of Down syndrome.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  4. Article
  5. The biogenesis and biology of amyloid β oligomers in the brain.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2020
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade.Journal of Alzheimer's disease : JAD · 2018
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Angie C A ChiangDepartment of Neuroscience, Huffington Center on Aging, Baylor College of Medicine, Houston, Texas.
Stephanie W FowlerDepartment of Neuroscience, Huffington Center on Aging, Baylor College of Medicine, Houston, Texas.
Rohit ReddyDepartment of Neuroscience, Huffington Center on Aging, Baylor College of Medicine, Houston, Texas; Department of Cognitive Science, Rice University, Houston, Texas.
Olga PletnikovaDivision of Neuropathology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Juan C TroncosoDivision of Neuropathology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Mathew A ShermanDepartment of Neuroscience, N. Bud Grossman Center for Memory Research and Care, Institute for Translational Neuroscience, University of Minnesota, Minneapolis, Minnesota.
Sylvain E LesneDepartment of Neuroscience, N. Bud Grossman Center for Memory Research and Care, Institute for Translational Neuroscience, University of Minnesota, Minneapolis, Minnesota.
Joanna L JankowskyDepartment of Neuroscience, Huffington Center on Aging, Baylor College of Medicine, Houston, Texas; Department of Neurology and Neurosurgery, Huffington Center on Aging, Baylor College of Medicine, Houston, Texas. Electronic address: jankowsk@bcm.edu.

Funding

Project 2 MeasurementU19AG033655 · NIA · JOHNS HOPKINS UNIVERSITY · PI Mei Cheng Wang · 2014 to 2026
$51.5M
'T V ASSESSMENT - MEMORY DISORDERED PATIENTS'P50AG005146 · NIA · JOHNS HOPKINS UNIVERSITY · PI HUGANIR, RICHARD L · 1985 to 2019
$37.6M
Biomarkers of Cognitive Decline among Normal Individuals: The BIOCARD cohortU01AG033655 · NIA · JOHNS HOPKINS UNIVERSITY · PI ALBERT, MARILYN S. · 2009 to 2013
$11.2M
TOWARD A MODEL OF ALZHEIMERS DISEASER01NS033249 · NINDS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI ASHE, KAREN H · 1994 to 2013
$6.5M
CELL &MOLECULAR BIOLOGY OF AGINGT32AG000183 · NIA · BAYLOR COLLEGE OF MEDICINE · PI DONEHOWER, LAWRENCE A. · 1989 to 2015
$3.7M
Selective neuronal silencing to study cognitive decline in Alzheimer's diseaseDP2OD001734 · OD · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI JANKOWSKY, JOANNA L · 2007 to 2010
$2.4M
Deconstructing the pathogenic effect of APP in memory circuitsR01NS092615 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI JANKOWSKY, JOANNA L · 2015 to 2018
$1.9M
Soluble aSyn is a modulator of AD pathophysiologyR01AG044342 · NIA · UNIVERSITY OF MINNESOTA · PI LESNE, SYLVAIN E. · 2014 to 2018
$1.5M
Mechanism of Action of ABeta*56 in Alzheimer's DiseaseR00AG031293 · NIA · UNIVERSITY OF MINNESOTA · PI LESNE, SYLVAIN E. · 2010 to 2012
$693k
NIA NIH HHS P50 AG005146NIA NIH HHS R00 AG031293NIA NIH HHS R01 AG044342NIA NIH HHS T32 AG000183NIA NIH HHS U01 AG033655NIA NIH HHS U19 AG033655NIH HHS DP2 OD001734NINDS NIH HHS R01 NS033249NINDS NIH HHS R01 NS092615
6 · The paper itself

Abstract

Despite increasing appreciation that oligomeric amyloid-β (Aβ) may contribute to cognitive decline of Alzheimer disease, defining the most critical forms has been thwarted by the changeable nature of these aggregates and the varying methods used for detection. Herein, using a broad approach, we quantified Aβ oligomers during the evolution of cognitive deficits in an aggressive model of Aβ amyloidosis. Amyloid precursor protein/tetracycline transactivator mice underwent behavioral testing at 3, 6, 9, and 12 months of age to evaluate spatial learning and memory, followed by histologic assessment of amyloid burden and biochemical characterization of oligomeric Aβ species. Transgenic mice displayed progressive impairments in acquisition and immediate recall of the trained platform location. Biochemical analysis of cortical extracts from behaviorally tested mice revealed distinct age-dependent patterns of accumulation in multiple oligomeric species. Dot blot analysis demonstrated that nonfibrillar Aβ oligomers were highly soluble and extracted into a fraction enriched for extracellular proteins, whereas prefibrillar species required high-detergent conditions to retrieve, consistent with membrane localization. Low-detergent extracts tested by 82E1 enzyme-linked immunosorbent assay confirmed the presence of bona fide Aβ oligomers, whereas immunoprecipitation-Western blotting using high-detergent extracts revealed a variety of SDS-stable low-n species. These findings show that different Aβ oligomers vary in solubility, consistent with distinct localization, and identify nonfibrillar Aβ oligomer-positive aggregates as tracking most closely with cognitive decline in this model.

Indexed as

AgedAged, 80 and overAlzheimer DiseaseAmyloid beta-PeptidesAnimalsBrainDisease Models, AnimalFemaleHumansMaleMiceMice, TransgenicMiddle AgedMotor ActivitySpatial LearningSpatial MemoryAmyloid beta-Peptides

Identifiers

PMID29248459
PMCPMC5840490

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.